Navigo Proteins Successfully Develops Affinity Resin Against Ferritin for Blood Fraction Processing
Affinity resin enables efficient capture of Ferritin from blood fractions despite low serum concentrationsHALLE/SAALE, Germany, July 20, 2022 / B3C newswire / -- Navigo Proteins GmbH (“Navigo”), a premier protein engineering company and developer of affinity ligands for custom chromatography solutions, t...
Source: pharmiweb.com